The global Alzheimer’s diagnostics and therapeutics market is expected to enjoy a valuation of USD 6.6 Billion by the end of the year 2023, and further expand at a CAGR of 8.4% to reach a valuation of USD 14.8 Billion by the year 2033. According to a recent study by Future Market Insights, diagnostics is leading the market with a share of about 54.1% in the year 2022, within the global market.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 6.1 Billion |
| Market Value 2023 | USD 6.6 Billion |
| Market Value 2033 | USD 14.8 Billion |
| CAGR 2023 to 2032 | 8.4% |
| Market Share of Top 5 Countries | 68.2% |
| Key Market Players | Biogen Inc.; AbbVie, Inc.; Teva Pharmaceuticals Ltd.; Eisai Co., Ltd.; Janssen Pharmaceuticals, Inc.; Novartis AG; Zydus Lifesciences Ltd; Sun Pharmaceutical Industries Ltd.; Dr. Reddy's Laboratories Ltd.; Aurobindo Pharma Ltd.; AMillioneal Pharmaceuticals Inc.; Macleods Pharmaceuticals Ltd.; Viatris Inc.; Lupin Ltd; Cipla Ltd.; Torrent pharmaceuticals Ltd.; Unichem laboratories Ltd.; and Lannett Inc. |
With the aging population and longer life expectancy, the prevalence of Alzheimer's disease is increasing worldwide. This has led to a growing demand for early and accurate diagnosis and effective treatments. Researchers are exploring personalized medicine approaches to Alzheimer's treatment, tailoring therapies to a patient's unique genetic and molecular profile. This approach may lead to more effective treatments with fewer side effects.
Overall, the market is projected to expand in the coming years, driven by an aging population and increasing demand for effective treatments, and will boost the overall growth of the Alzheimer’s diagnostics and therapeutics market during the forecast period (2022 to 2033).
The market value for Alzheimer’s diagnostics and therapeutics was 43.1% of the overall USD 14.2 Billion of the global dementia treatment market in 2022.
The growing burden of Alzheimer's disease increased the sales of Alzheimer's diagnostics and therapeutics in the market. As the population ages and the number of people with Alzheimer's disease increases, there will likely be greater demand for diagnostic tests and treatments that can help manage the disease.
Alzheimer's disease is a progressive disease, which means that it worsens over time. Early and accurate diagnosis is critical to assisting patients and cares with treatment planning and options. A safe and reliable test that is able to precisely detect patients with amyloid plaques in Alzheimer's patients is still lacking. Recently the FDA has approved the first IVD (in vitro diagnostic test) for the early diagnosis of amyloid plaques linked with Alzheimer's disease is being marketed. The Lumipulse G-Amyloid Ratio test is designed for use in adult patients who are 55 years of age or older with cognitive impairment and are being assessed for Alzheimer's disease and other roots of cognitive decline.
Thus, advances in technology and research may lead to the development of new and more effective diagnostic tools and therapies, which could further increase the sales of these products and is expected to boost demand for the global Alzheimer’s diagnostics and therapeutics market is projected to expand at a CAGR of 8.4% during the forecast period (2023 to 2032).
The market has significant growth opportunities due to the increasing prevalence of Alzheimer's disease (AD) worldwide.
There is a growing interest in developing biomarker-based diagnostics for Alzheimer's disease. Biomarkers can help to identify individuals at risk of developing AD, track disease progression, and assess treatment response. There is a need for reliable and accurate biomarkers that can be used in clinical practice. There is a significant need for Alzheimer's diagnostics and therapeutics in emerging markets, such as Asia and Latin America, where the prevalence of the disease is increasing rapidly. Companies that can successfully penetrate these markets could see significant growth opportunities.
The market presents significant opportunities for companies that can develop innovative and effective solutions for the diagnosis and treatment of this devastating disease in both developed and developing regions will raise the market to new heights during the forecast period from 2023 to 2033.
The high cost of Alzheimer's disease diagnosis is one of the significant factors that will likely stymie the growth of the Alzheimer's disease diagnostic market. Given the resources deployed to prevent, diagnose, treat, and manage dementia, the economic costs of AD are significant for the health system. The societal costs of dementia extend beyond these direct costs, as the disease has an economic and quality-of-life impact on individuals, families, and careers.
According to some studies, the direct and indirect costs of Alzheimer's disease-related healthcare are very high. Alzheimer's disease necessitates post-mortem assessment of brain tissue via positron emission tomography (PET) and cerebrospinal fluid (CSF) biomarkers, as well as several innovative clinical criteria that can aid diagnosis in patients. The cost of a true dementia diagnosis is calculated by dividing the total cost of all investigations by the number of final dementia diagnoses. The unit costs for the various components of the diagnostic process are used to assess all costs.
Aligned with the global aging population, the global prevalence of Alzheimer's disease is expected to rise exponentially in the coming decades. As a result, the costs of AD have come under increased scrutiny, and projections have been made which are restraining the growth of the Alzheimer's diagnostics and therapeutics market during the forecast period from 2023 to 2033 in the world.
With a market share of 89.7% in 2022, theUSA continue to dominate the North American region. This large market share is expected to continue throughout the forecast period.
The United States has one of the maximum prevalence rates of Alzheimer's disease in the world.
Additionally, the combination of an aging population, high prevalence of Alzheimer's disease, high healthcare spending, and strong research infrastructure make the United States an attractive market for Alzheimer's diagnostics and therapeutics.
This will result in the propulsion of demand for Alzheimer’s diagnostics and therapeutics in the country during the forecast period of 2023 to 2033.
The United Kingdom dominates the European region with a total market share of about 39.6% in 2022 and is expected to continue to experience the same growth throughout the forecast period.
The United Kingdom has an aging population, which increases the demand for Alzheimer's diagnostics and therapeutics. As people live longer, the prevalence of Alzheimer's disease increases, and the United Kingdom is expected to see a significant rise in the number of people living with the disease in the coming years.
The United Kingdom government has shown a commitment to funding research into Alzheimer's disease, with investments in both public and private sector research. This support helps to attract investment from pharmaceutical companies, which are crucial for bringing new diagnostics and therapeutics to market and will foster profitable growth of the market over the course of the forecast period.
Japan in the East Asia region holds a market share of 60.4% in 2022 and will expand with growing numbers in the future.
Japan has a robust research infrastructure, with many leading research institutions dedicated to studying Alzheimer's disease. The country is home to a few of the world's top pharmaceutical companies, and the Japanese government has made significant investments in research and development in this area.
The aging population, strong research infrastructure, innovative technologies, and supportive government policies all suggest that Japan will continue to be an important market for Alzheimer's diagnostics and therapeutics.
Diagnostics is expected to present high growth at a CAGR of 7.5% throughout the forecast period, with a market share of 54.1% in the global market in 2022. Recent technological advancements in diagnostic testing have led to the development of more accurate and reliable tests for Alzheimer's disease. These advances have helped to increase the adoption of diagnostic testing and drive market growth.
As the demand for reliable and accurate diagnostic tests continues to grow, the market for Alzheimer's diagnostics is expected to expand significantly in the coming years.
Institutional sales hold the market share value of 57.9% during the year 2022. Institutional sales by distribution channels allow hospitals and clinics to purchase the necessary equipment and drugs needed to treat patients with Alzheimer's disease and also enable manufacturers to expand their market reach. By partnering with hospitals and clinics, manufacturers can reach a larger patient population and increase sales of their products.
Thus, institutional sales are expected to benefit the most from the sales of Alzheimer's diagnostics and therapeutics globally in the next decade.
Manufacturers invest heavily in research and development to discover new diagnostic tools and treatments for Alzheimer's disease. Some manufacturers may diversify their product offerings to include a range of diagnostic and therapeutic options for Alzheimer's disease.
Acquisitions, collaboration, and clinical trials significantly accelerate the manufacturer’s ability to capture a significant share of the market. A few of the recent instances include
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2012 to 2022 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Vietnam, Philippines, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, Israel, North Africa, and South Africa |
| Key Market Segments Covered | Product, Distribution Channel, and Region |
| Key Companies Profiled | Biogen Inc.; AbbVie, Inc.; Teva Pharmaceuticals Ltd.; Eisai Co.; Ltd.; Janssen Pharmaceuticals Inc.; Novartis AG; Zydus Lifesciences Ltd.; Sun Pharmaceutical Industries Ltd.; Dr. Reddy's Laboratories Ltd.; Aurobindo Pharma Ltd.; AMillioneal Pharmaceuticals Inc.; Macleods Pharmaceuticals Ltd.; Viatris Inc.; Lupin Ltd.; Cipla Ltd.; Torrent pharmaceuticals Ltd.; Unichem Laboratories Ltd.; Lannett Inc. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
Table 01: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 02: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 03: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 04: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 05: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Region
Table 06: North America Market Size Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 07: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 08: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 09: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 10: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 11: Latin America Market Size Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 12: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 13: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 14: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 15: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 16: Europe Market Size Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 17: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 18: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 19: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 20: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 21: East Asia Market Size Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 22: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 23: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 24: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 25: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 26: South Asia Market Size Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 27: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 28: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 29: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 30: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 31: Oceania Market Size Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 32: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 33: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 34: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 35: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 36: Middle East and Africa Market Size Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 37: Middle East and Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 38: Middle East and Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
Table 39: Middle East and Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 40: Middle East and Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Figure 01: Global Market Value Analysis (US$ Million), 2012 to 2022
Figure 02: Global Market Value Forecast (US$ Million), 2022 to 2033
Figure 03: Global Market Absolute $ Opportunity, 2022 to 2033
Figure 04: Global Market Share Analysis (%), By Product Type, 2023 & 2033
Figure 05: Global Market Y-o-Y Analysis (%), By Product, 2023 to 2033
Figure 06: Global Market Attractiveness Analysis By Product, 2023 to 2033
Figure 07: Global Market Share Analysis (%), By Distribution Channel, 2023 & 2033
Figure 08: Global Market Y-o-Y Analysis (%), By Distribution Channel, 2023 to 2033
Figure 09: Global Market Attractiveness Analysis By Distribution Channel, 2023 to 2033
Figure 10: Global Market Share Analysis (%), By Region, 2023 & 2033
Figure 11: Global Market Y-o-Y Analysis (%), By Region, 2023 to 2033
Figure 12: Global Market Attractiveness Analysis By Region, 2023 to 2033
Figure 13: North America Market Split By Country, 2023 (E)
Figure 14: North America Market Split By Product, 2023 (E)
Figure 15: North America Market Split By Distribution Channel, 2023 (E)
Figure 16: North America Market Value Analysis (US$ Million), 2012 to 2022
Figure 17: North America Market Value Forecast (US$ Million), 2022 to 2033
Figure 18: North America Market Attractiveness Analysis By Product, 2023 to 2033
Figure 19: North America Market Attractiveness Analysis By Distribution Channel, 2023 to 2033
Figure 20: North America Market Attractiveness Analysis By Country, 2023 to 2033
Figure 21: U.S Market Value Proportion Analysis, 2022
Figure 22: Global Vs. U.S Growth Comparison, 2023 to 2033
Figure 23: U.S. Market Share Analysis (%) By Product, 2022 & 2033
Figure 24: U.S. Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 25: Canada Market Value Proportion Analysis, 2022
Figure 26: Global Vs. Canada Growth Comparison, 2023 to 2033
Figure 27: Canada Market Share Analysis (%) By Product, 2022 & 2033
Figure 28: Canada Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 29: Latin America Market Split By Country, 2023 (E)
Figure 30: Latin America Market Split By Product, 2023 (E)
Figure 31: Latin America Market Split By Distribution Channel, 2023 (E)
Figure 32: Latin America Market Value Analysis (US$ Million), 2012 to 2022
Figure 33: Latin America Market Value Forecast (US$ Million), 2022 to 2033
Figure 34: Latin America Market Attractiveness Analysis By Product, 2023 to 2033
Figure 35: Latin America Market Attractiveness Analysis By Distribution Channel, 2023 to 2033
Figure 36: Latin America Market Attractiveness Analysis By Country, 2023 to 2033
Figure 37: Brazil Market Value Proportion Analysis, 2022
Figure 38: Global Vs. Brazil Growth Comparison, 2023 to 2033
Figure 39: Brazil Market Share Analysis (%) By Product, 2022 & 2033
Figure 40: Brazil. Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 41: Mexico Market Value Proportion Analysis, 2022
Figure 42: Global Vs. Mexico Growth Comparison, 2023 to 2033
Figure 43: Mexico Market Share Analysis (%) By Product, 2022 & 2033
Figure 44: Mexico Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 45: Argentina Market Value Proportion Analysis, 2022
Figure 46: Global Vs. Argentina Growth Comparison, 2023 to 2033
Figure 47: Argentina Market Share Analysis (%) By Product, 2022 & 2033
Figure 48: Argentina Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 49: Europe Market Split By Country, 2023 (E)
Figure 50: Europe Market Split By Product, 2023 (E)
Figure 51: Europe Market Split By Distribution Channel, 2023 (E)
Figure 52: Europe Market Value Analysis (US$ Million), 2012 to 2022
Figure 53: Europe Market Value Forecast (US$ Million), 2022 to 2033
Figure 54: Europe Market Attractiveness Analysis By Product, 2023 to 2033
Figure 55: Europe Market Attractiveness Analysis By Distribution Channel, 2023 to 2033
Figure 56: Europe Market Attractiveness Analysis By Country, 2023 to 2033
Figure 57: Germany Market Value Proportion Analysis, 2022
Figure 58: Global Vs. Germany Growth Comparison, 2023 to 2033
Figure 59: Germany Market Share Analysis (%) By Product, 2022 & 2033
Figure 60: Germany Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 61: Italy Market Value Proportion Analysis, 2022
Figure 62: Global Vs. Italy Growth Comparison, 2023 to 2033
Figure 63: Italy Market Share Analysis (%) By Product, 2022 & 2033
Figure 64: Italy Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 65: France Market Value Proportion Analysis, 2022
Figure 66: Global Vs. France Growth Comparison, 2023 to 2033
Figure 67: France Market Share Analysis (%) By Product, 2022 & 2033
Figure 68: France Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 69: United kingdom Market Value Proportion Analysis, 2022
Figure 70: Global Vs. United kingdom Growth Comparison, 2023 to 2033
Figure 71: United kingdom Market Share Analysis (%) By Product, 2022 & 2033
Figure 72: United kingdom Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 73: Spain Market Value Proportion Analysis, 2022
Figure 74: Global Vs. Spain Growth Comparison, 2023 to 2033
Figure 75: Spain Market Share Analysis (%) By Product, 2022 & 2033
Figure 76: Spain Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 77: BENELUX Market Value Proportion Analysis, 2022
Figure 78: Global Vs. BENELUX Growth Comparison, 2023 to 2033
Figure 79: BENELUX Market Share Analysis (%) By Product, 2022 & 2033
Figure 80: BENELUX Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 81: Russia Market Value Proportion Analysis, 2022
Figure 82: Global Vs. Russia Growth Comparison, 2023 to 2033
Figure 83: Russia Market Share Analysis (%) By Product, 2022 & 2033
Figure 84: Russia Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 85: Nordic Countries Market Value Proportion Analysis, 2022
Figure 86: Global Vs. Nordic Countries Growth Comparison, 2023 to 2033
Figure 87: Nordic Countries Market Share Analysis (%) By Product, 2022 & 2033
Figure 88: Nordic Countries Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 89: East Asia Market Split By Country, 2023 (E)
Figure 90: East Asia Market Split By Product, 2023 (E)
Figure 91: East Asia Market Split By Distribution Channel, 2023 (E)
Figure 92: East Asia Market Value Analysis (US$ Million), 2012 to 2022
Figure 93: East Asia Market Value Forecast (US$ Million), 2022 to 2033
Figure 94: East Asia Market Attractiveness Analysis By Product, 2023 to 2033
Figure 95: East Asia Market Attractiveness Analysis By Distribution Channel, 2023 to 2033
Figure 96: East Asia Market Attractiveness Analysis By Country, 2023 to 2033
Figure 97: China Market Value Proportion Analysis, 2022
Figure 98: Global Vs. China Growth Comparison, 2023 to 2033
Figure 99: China Market Share Analysis (%) By Product, 2022 & 2033
Figure 100: China Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 101: Japan Market Value Proportion Analysis, 2022
Figure 102: Global Vs. Japan Growth Comparison, 2023 to 2033
Figure 103: Japan Market Share Analysis (%) By Product, 2022 & 2033
Figure 104: Japan Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 105: South Korea Market Value Proportion Analysis, 2022
Figure 106: Global Vs. South Korea Growth Comparison, 2023 to 2033
Figure 107: South Korea Market Share Analysis (%) By Product, 2022 & 2033
Figure 108: South Korea Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 109: South Asia Market Split By Country, 2023 (E)
Figure 110: South Asia Market Split By Product, 2023 (E)
Figure 111: South Asia Market Split By Distribution Channel, 2023 (E)
Figure 112: South Asia Market Value Analysis (US$ Million), 2012 to 2022
Figure 113: South Asia Market Value Forecast (US$ Million), 2022 to 2033
Figure 114: South Asia Market Attractiveness Analysis By Product, 2023 to 2033
Figure 115: South Asia Market Attractiveness Analysis By Distribution Channel, 2023 to 2033
Figure 116: South Asia Market Attractiveness Analysis By Country, 2023 to 2033
Figure 117: India Market Value Proportion Analysis, 2022
Figure 118: Global Vs. India Growth Comparison, 2023 to 2033
Figure 119: India Market Share Analysis (%) By Product, 2022 & 2033
Figure 120: India Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 121: Indonesia Market Value Proportion Analysis, 2022
Figure 122: Global Vs. Indonesia Growth Comparison, 2023 to 2033
Figure 123: Indonesia Market Share Analysis (%) By Product, 2022 & 2033
Figure 124: Indonesia Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 125: Malaysia Market Value Proportion Analysis, 2022
Figure 126: Global Vs. Malaysia Growth Comparison, 2023 to 2033
Figure 127: Malaysia Market Share Analysis (%) By Product, 2022 & 2033
Figure 128: Malaysia Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 129: Philippines Market Value Proportion Analysis, 2022
Figure 130: Global Vs. Philippines Growth Comparison, 2023 to 2033
Figure 131: Philippines Market Share Analysis (%) By Product, 2022 & 2033
Figure 132: Philippines Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 133: Thailand Market Value Proportion Analysis, 2022
Figure 134: Global Vs. Thailand Growth Comparison, 2023 to 2033
Figure 135: Thailand Market Share Analysis (%) By Product, 2022 & 2033
Figure 136: Thailand Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 137: Vietnam Market Value Proportion Analysis, 2022
Figure 138: Global Vs. Vietnam Growth Comparison, 2023 to 2033
Figure 139: Vietnam Market Share Analysis (%) By Product, 2022 & 2033
Figure 140: Vietnam Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 141: Oceania Market Split By Country, 2023 (E)
Figure 142: Oceania Market Split By Product, 2023 (E)
Figure 143: Oceania Market Split By Distribution Channel, 2023 (E)
Figure 144: Oceania Market Value Analysis (US$ Million), 2012 to 2022
Figure 145: Oceania Market Value Forecast (US$ Million), 2022 to 2033
Figure 146: Oceania Market Attractiveness Analysis By Product, 2023 to 2033
Figure 147: Oceania Market Attractiveness Analysis By Distribution Channel, 2023 to 2033
Figure 148: Oceania Market Attractiveness Analysis By Country, 2023 to 2033
Figure 149: Australia Market Value Proportion Analysis, 2022
Figure 150: Global Vs. Australia Growth Comparison, 2023 to 2033
Figure 151: Australia Market Share Analysis (%) By Product, 2022 & 2033
Figure 152: Australia Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 153: New Zealand Market Value Proportion Analysis, 2022
Figure 154: Global Vs. New Zealand Growth Comparison, 2023 to 2033
Figure 155: New Zealand Market Share Analysis (%) By Product, 2022 & 2033
Figure 156: New Zealand Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 157: Middle East and Africa Market Split By Country, 2023 (E)
Figure 158: Middle East and Africa Market Split By Product, 2023 (E)
Figure 159: Middle East and Africa Market Split By Distribution Channel, 2023 (E)
Figure 160: Middle East and Africa Market Value Analysis (US$ Million), 2012 to 2022
Figure 161: Middle East and Africa Market Value Forecast (US$ Million), 2022 to 2033
Figure 162: Middle East and Africa Market Attractiveness Analysis By Product, 2023 to 2033
Figure 163: Middle East and Africa Market Attractiveness Analysis By Distribution Channel, 2023 to 2033
Figure 164: Middle East and Africa Market Attractiveness Analysis By Country, 2023 to 2033
Figure 165: GCC Countries Market Value Proportion Analysis, 2022
Figure 166: Global Vs. GCC Countries Growth Comparison, 2023 to 2033
Figure 167: GCC Countries Market Share Analysis (%) By Product, 2022 & 2033
Figure 168: GCC Countries Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 169: Türkiye Market Value Proportion Analysis, 2022
Figure 170: Global Vs. Türkiye Growth Comparison, 2023 to 2033
Figure 171: Türkiye Market Share Analysis (%) By Product, 2022 & 2033
Figure 172: Türkiye Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 173: Israel Market Value Proportion Analysis, 2022
Figure 174: Global Vs. Israel Growth Comparison, 2023 to 2033
Figure 175: Israel Market Share Analysis (%) By Product, 2022 & 2033
Figure 176: Israel Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 177: North Africa Market Value Proportion Analysis, 2022
Figure 178: Global Vs. North Africa Growth Comparison, 2023 to 2033
Figure 179: North Africa Market Share Analysis (%) By Product, 2022 & 2033
Figure 180: North Africa Market Share Analysis (%) By Distribution Channel, 2022 & 2033
Figure 181: South Africa Market Value Proportion Analysis, 2022
Figure 182: Global Vs. South Africa Growth Comparison, 2023 to 2033
Figure 183: South Africa Market Share Analysis (%) By Product, 2022 & 2033
Figure 184: South Africa Market Share Analysis (%) By Distribution Channel, 2022 & 2033
The market will register a 9.2% CAGR through 2033.
Increasing incidences of alzheimer drive market expansion.
From 2018 to 2022, the market expanded at a 6.8% CAGR.
The United States held a market share of 94% in 2022.
By 2033, the market will reach USD 7,359.7 million.
Explore Similar Insights
Alzheimer's Diagnostics and Therapeutics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
